The Interaction Between Iron and Selenium Affects Ferroptosis in Colorectal Cancer.

Area of Science:

• Oncology
• Cell Death Mechanisms
• Biochemistry

Background:

• Colorectal cancer (CRC) is a leading cause of cancer mortality, with treatment resistance limiting patient outcomes.
• Ferroptosis, an iron-dependent cell death, presents a promising therapeutic avenue for CRC.
• Current models of ferroptosis sensitivity in CRC, focusing on GPX4 and SLC7A11, are incomplete.

Purpose of the Study:

• To review the mechanisms regulating ferroptosis in colorectal cancer.
• To explore the roles of iron trafficking and selenium-dependent antioxidant defense in ferroptosis.
• To identify potential therapeutic strategies by understanding the interplay between these pathways.

Main Methods:

• Literature review of studies on ferroptosis, iron metabolism, and selenium biochemistry in colorectal cancer.
• Analysis of the PCBP1/2-NCOA4 axis in iron regulation and ferritinophagy.
• Examination of the ALKBH8-directed selenoprotein network in redox homeostasis and lipid peroxide detoxification.

Main Results:

• The PCBP1/2-NCOA4 axis critically regulates iron storage, trafficking, and ferritinophagy.
• The ALKBH8-directed selenoprotein network is vital for detoxifying lipid peroxides and maintaining redox balance.
• The interplay between iron handling and selenium-dependent defense significantly impacts ferroptosis sensitivity in CRC cells.

Conclusions:

• Ferroptosis sensitivity in CRC is modulated by complex interactions between iron metabolism and selenium-dependent antioxidant systems.
• Concurrent targeting of iron dysregulation and impaired selenium defense may enhance ferroptosis-inducing cancer therapies.
• Further research into these pathways could lead to novel combination strategies and biomarkers for CRC treatment.